| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
WiserTogether`s personalized healthcare treatment comparison software enables consumers to choose the right treatment – most effective in outcome, most personally suitable, and most cost-effective and affordable. The result is improved health and improved costs for consumers, their employers, payers and providers. The company serves over 3 million people through their employers and health plans.
Kimochi Home is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EraGen Biosciences, Inc. is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DR Management LLC is a Fort Wayne, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.